Six-month-old cancer startup makes $166M Nasdaq debut
July 29, 2021 at 13:05 PM EDT
Almost exactly six months after emerging from stealth, cancer startup Nuvalent is hitting the public markets in a $166 million IPO.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|